These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. B7-H3 promotes nasopharyngeal carcinoma progression by regulating CD8+ T cell exhaustion. Ma Z; Chen G; Li H; Yang S; Xu Y; Pan B; Lai W; Chen G; Liao W; Zhang X Immun Inflamm Dis; 2024 Sep; 12(9):e70005. PubMed ID: 39267471 [TBL] [Abstract][Full Text] [Related]
5. [A negative correlation between B7-H3 expression and the number of CD8+ T cell infiltration in primary hepatocellular carcinoma tissues]. Liu T; Huo Y; Li G; Yu G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Dec; 30(12):1291-4. PubMed ID: 25481188 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3. Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841 [TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection. Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143 [TBL] [Abstract][Full Text] [Related]
8. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558 [TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint molecules are regulated by transforming growth factor (TGF)- Shrestha R; Bridle KR; Crawford DHG; Jayachandran A Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078 [TBL] [Abstract][Full Text] [Related]
10. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function. Lee YH; Martin-Orozco N; Zheng P; Li J; Zhang P; Tan H; Park HJ; Jeong M; Chang SH; Kim BS; Xiong W; Zang W; Guo L; Liu Y; Dong ZJ; Overwijk WW; Hwu P; Yi Q; Kwak L; Yang Z; Mak TW; Li W; Radvanyi LG; Ni L; Liu D; Dong C Cell Res; 2017 Aug; 27(8):1034-1045. PubMed ID: 28685773 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Kang FB; Wang L; Li D; Zhang YG; Sun DX Oncol Rep; 2015 Jan; 33(1):274-82. PubMed ID: 25370943 [TBL] [Abstract][Full Text] [Related]
13. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer. Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027 [TBL] [Abstract][Full Text] [Related]
14. Diet restriction enhances the effect of immune checkpoint block by inhibiting the intratumoral mTORC1/B7-H3 axis. Xiao D; Liu T; Pan Y J Biochem Mol Toxicol; 2024 Aug; 38(8):e23803. PubMed ID: 39132973 [TBL] [Abstract][Full Text] [Related]
15. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345 [TBL] [Abstract][Full Text] [Related]
16. B7-H3 immunoregulatory roles in cancer. Mortezaee K Biomed Pharmacother; 2023 Jul; 163():114890. PubMed ID: 37196544 [TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma]. Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248 [TBL] [Abstract][Full Text] [Related]
18. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration. Li L; Nian S; Liu Q; Zhang B; Jimu W; Li C; Huang Z; Hu Q; Huang Y; Yuan Q Int Immunopharmacol; 2024 May; 132():111926. PubMed ID: 38552297 [TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis. Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]